The case involved Northern Trust Bank suing Wells Fargo Bank over an $8 million loan repayment made by debtor El-Atari to Wells Fargo using funds borrowed from Northern Trust, after El-Atari's bankruptcy filing. The court granted Wells Fargo's motion for summary judgment and dismissed the case. The core reasoning was that Northern Trust, as a creditor, lacked standing to pursue claims challenging the transfer because those claims belonged to the bankruptcy estate under Fourth Circuit precedent in National American Insurance Co. v. Ruppert Landscaping Co., and only the bankruptcy trustee could assert them regardless of the legal theory.
The case concerned whether The Medicines Company timely filed a patent term extension application for its anticoagulant drug ANGIOMAX under the Hatch-Waxman Act after receiving FDA approval. The court held that the application was timely, interpreting the 60-day filing period under 35 U.S.C. § 156(d)(1) to begin on the next business day following the FDA's after-hours transmission of the approval letter on December 15, 2000. The reasoning focused on the statute's remedial purpose to compensate for regulatory delays, consistency with the FDA's own business-day practices for submissions, the need for fair notice to applicants, and ensuring patent holders receive the full period Congress intended.
The case involves a plaintiff suing a grocery store operator for negligence after she slipped and fell in a store aisle in 2005, claiming she was injured by sugar, flour, or a lollipop stick on the floor. The court granted the defendants' motion for summary judgment. The core reasoning was that the plaintiff failed to make a prima facie case of negligence, as she did not know what caused her fall, had not seen or felt any hazard before falling, could only speculate about any dangerous condition, and provided no evidence that any such condition proximately caused her injuries.
The case involved homeowners who defaulted on two mortgage loans originated to purchase property in 2006 and who filed suit just before a scheduled foreclosure, seeking declaratory judgment and quiet title on grounds that note transfers through securitization split the notes and deeds of trust, that credit enhancements or swaps would produce an unlawful double recovery, and that no party had authority to foreclose. The district court granted summary judgment to the defendants. The court reasoned that the first note was validly endorsed and transferred, MERS properly assigned deed-of-trust rights to the servicer Litton, Litton held authority to collect and foreclose under Virginia law, and the plaintiffs' securitization-splitting and double-recovery theories had no basis in statute or precedent because credit default swaps are separate contracts and foreclosure by trustees of securitized mortgages is routine.
The case was a challenge under the Administrative Procedure Act to the Patent and Trademark Office's denial of a patent term extension application for the anticoagulant drug ANGIOMAX, filed by The Medicines Company under the Hatch-Waxman Act. The PTO denied the extension as untimely, accepting the FDA's determination that approval occurred on December 15, 2000, which started the 60-day filing clock under 35 U.S.C. § 156(d)(1) one day before the February 14, 2001 submission. The court vacated the PTO's decision and remanded for reconsideration, holding that the PTO had independent authority to interpret the distinct statutory trigger of when the product "received permission" for commercial marketing and was not bound by the FDA's approval date analysis under § 156(g)(1)(B)(ii).
business & regulatoryhealthcarefederal powerprocedure
The case involved Citigroup suing a Chinese resident who registered and used the domain name citybank.org to provide links to financial services and receive compensation from third-party vendors, claiming a violation of the Anticybersquatting Consumer Protection Act. The court granted the plaintiff's motion for summary judgment, finding the defendant liable for registering and using the domain name. The decision rested on evidence that the defendant had a bad faith intent to profit from the domain, including its commercial use for click-through revenue without any rights to the marks, and that citybank.org was confusingly similar to Citigroup's distinctive and famous CITI and CITIBANK trademarks used for banking services. The court awarded the maximum statutory damages of $100,000, attorneys' fees, and a permanent injunction against further infringement.